Astera Labs (NASDAQ:ALAB) Trading 2.1% Higher – What’s Next?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) rose 2.1% on Wednesday . The company traded as high as $326.97 and last traded at $325.33. Approximately 5,117,810 shares traded hands during mid-day trading, a decline of 8% from the average daily volume of 5,543,899 shares. The stock had previously closed at $318.72.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs announced it will host press conferences, live demos, and technical talks at Computex 2026, where it will showcase AI infrastructure connectivity products including the Scorpio X-Series 320 Lane Smart Fabric Switch, optical connectivity, and COSMOS-enabled validation tools. The event could increase visibility with analysts, customers, and ecosystem partners. Article Title
• Positive Sentiment: Recent coverage highlighted ALAB’s sharp momentum and noted bullish analyst views, reinforcing optimism around Astera Labs’ role in AI networking and semiconductor infrastructure. Article Title
• Positive Sentiment: The company’s recent earnings report was strong, with revenue up 93.5% year over year and EPS beating estimates, while guidance also pointed to continued growth. This supports the rally in ALAB shares.
• Neutral Sentiment: Astera Labs presented at TD Cowen’s Technology, Media & Telecom conference, but the transcript does not appear to include a major new catalyst that would materially change the near-term outlook.
• Negative Sentiment: Insider selling remains a concern: General Counsel Philip Mazzara sold 796 shares, and COO Sanjay Gajendra sold 400,000 shares under a pre-arranged trading plan. While not necessarily a fundamental red flag, heavy insider sales can pressure sentiment after a big run-up. Article Title
• Negative Sentiment: Northland Securities downgraded Astera Labs from outperform to market perform, which may limit upside enthusiasm in the short term.

Analysts Set New Price Targets

ALAB has been the topic of a number of research reports. Susquehanna increased their price objective on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Loop Capital initiated coverage on Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price objective on the stock. Barclays increased their price objective on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday. Finally, Evercore reissued an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Stock Up 2.1%

The firm has a 50-day moving average of $178.09 and a two-hundred day moving average of $161.43. The company has a market capitalization of $55.76 billion, a PE ratio of 219.82, a PEG ratio of 4.06 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period last year, the business earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 2,316,257 shares of company stock worth $474,860,636. 12.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in ALAB. Atreides Management LP lifted its position in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after acquiring an additional 1,754,593 shares in the last quarter. Vanguard Group Inc. lifted its position in Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after buying an additional 1,693,918 shares in the last quarter. Amundi lifted its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC purchased a new position in Astera Labs during the third quarter worth approximately $209,599,000. Finally, BNP Paribas Financial Markets lifted its position in Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.